X
skip to main content
Logo
media conference

Press Releases

  • September 02, 2016

    2016 TRANSLATIONAL CANCER RESEARCH PROGRAM COMPETITION RECIPIENT

    Both around the world and in Canada, teams of researchers are working hard to harness the power of a patient’s own immune system to eradicate cancer through immunotherapy. Hailed now as the fourth arm of treatment, a newly funded TFRI pan-Canadian research team hopes this promising approach will give new hope and options to patients who need it the most.

  • September 02, 2016

    2016 NEW FRONTIERS PROGRAM PROJECT GRANTS COMPETITION RECIPIENT

    A newly funded TFRI “dream team” plans to tackle the most lethal and aggressive brain tumour that occurs in adults by focusing not on the original tumour, but on the relapsed cancer.

  • July 14, 2016

    “Smart” nanoparticle (PEARLs) a promising gem to target and treat tumours with greater precision

    Dr. Gang Zheng and a team of biomedical researchers have discovered a "smart," organic, biodegradable nanoparticle that uses heat and light in a controlled manner to potentially target and ablate tumours with greater precision.

  • July 14, 2016

    Stem cell scientists discover genetic switch to increase supply of stem cells from cord blood

    International stem cell scientists, co-led in Canada by Terry Fox-funded scientist Dr. John Dick and in the Netherlands by Dr. Gerald de Haan, have discovered the switch to harness the power of cord blood and potentially increase the supply of stem cells for cancer patients needing transplantation therapy to fight their disease.

  • June 14, 2016

    Study by TFRI-funded team underscores importance of accurate diagnosis for rare ovarian and other cancers

    Terry Fox-funded cancer researchers in BC led an international study to develop a new method to improve diagnosis of a rare sub-type of ovarian cancer that has been notoriously difficult to accurately identify. The team has created an algorithm to diagnose and predict the clinical course of granulosa cell cancers of the ovary.

  • June 03, 2016

    Terry Fox researcher leads international conference on ‘devastating’ cancer predisposition syndrome

    Terry Fox-funded researcher Dr. David Malkin, The Hospital for Sick Kids, Toronto, Ontario, was in Columbus, Ohio this week to co-lead the 2016 International Li-Fraumeni Syndrome (LFS) Conference. TFRI funds two projects led by Dr. Malkin, including one focusing solely on LFS.

  • April 22, 2016

    Dr. Victor Ling receives lifetime achievement award

    Congratulations to Dr. Victor Ling, TFRI's President and Scientific Director, who has been honoured with the LifeSciences BC Dr. Don Rix Award for Lifetime Achievement. The award celebrates his many contributions to cancer research over his career.

  • April 21, 2016

    Women more likely to survive cancer than men

    A report by Statistics Canada suggests that women have significantly better survival outcomes than men for a majority of cancers in Canada. While the reasons are not yet understood, hormonal influences are thought to be an important factor. The full report, "Differences in cancer survival in Canada by sex" can be read on the Statistics Canada website.

  • April 21, 2016

    2017 TFRI research competitions now open

    TFRI is now accepting submissions from researchers and research teams for our 2017 funding cycle. For more information see the competition pages for Terry Fox New Frontiers Program Project Grants, TFRI Translational Programs and Terry Fox New Investigator Awards.

  • March 15, 2016

    Rolland (Rolly) Murray Fox: 1935-2016

    Rolly Fox-smallRolland (Rolly) Murray Fox was born March 22, 1935 in Winnipeg, Manitoba. Rolly was the third of nine children born to Rodney Fox and Bertha (Shale) Fox...

  • February 10, 2016

    New Investigator hopes oxygen-enhanced cancer tumours will improve treatment outcomes

    Dr. Ralph DaCosta will use a $450,000 New Investigator award from TFRI to try to find new and innovative ways to study the complex tumor microenvironment to develop new treatment strategies for pancreatic cancer and prevent deadly tumour recurrences.

  • January 26, 2016

    Blue Light Shines Brightly as a Highly Useful Oral Cancer Surgery Tool

    Terry Fox-funded researchers find that fluorescence visualization may drastically reduce cancer recurrence by clearly differentiating cancer cells from healthy tissue.

  • November 30, 2015

    2015 Research Portfolio now online

    TFRI_Portfolio_2015_thumbA full list of Terry Fox-funded research programs can be found in our 2015 Terry Fox Cancer Research Portfolio. The portfolio includes a scientific summary for each program, a list of the Principal Investigators and key program publications.

  • April 20, 2015

    Pancreatic cancer loses viral defences when talking with supporting cells

    Ottawa, ON -- Terry Fox funded researchers in Ottawa have found a way to make pancreatic cancer cells more vulnerable to cancer-killing viruses, known as oncolytic viruses. In a paper published today in Nature Medicine, the scientists describe how they can exploit the communication, or cross-talk, between pancreatic cancer and a specific cell type that supports the tumour.

  • April 14, 2015

    Abstract deadline for CCRC 2015

    The Canadian Cancer Research Alliance’s 2015 Canadian Cancer Research Conference will be held November 8 to 10, 2015 in Montréal. This year TFRI is a gold supporter and part of the planning committee for the event. The deadline for abstract submissions is May 15, 2015. An Early Bird registration fee is available until August 31, 2015. For more information download the promotional leaflet or visit www.ccra-acrc.ca/conference.

Back to Top